We are live on
!
Find out more
LPT
Legacy Private Trust Portfolio holdings
AUM
$1.83B
Turnover
5.07%
1-Year Est. Return
13%
This Fund
S&P 500
This Quarter
Est. Return
+3.54%
1 Year Est. Return
+13%
3 Year Est. Return
+71.11%
5 Year Est. Return
+68.67%
10 Year Est. Return
+196.33%
AUM
$822M
AUM Growth
+$31.1M
(+3.9%)
Cap. Flow
+$5.89M
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
34.55%
Holding
253
New
23
Increased
60
Reduced
119
Closed
20
Avg Time Held
2.4
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$13.2M |
| 2 |
Invesco S&P 500 Pure Growth ETF
RPG
|
+$7.17M |
| 3 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$6.69M |
| 4 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$5.95M |
| 5 |
Invesco Emerging Markets Sovereign Debt ETF
PCY
|
+$5.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco FTSE RAFI Emerging Markets ETF
PXH
|
+$5.29M |
| 2 |
ULQ
CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF
ULQ
|
+$4.27M |
| 3 |
State Street Blackstone Senior Loan ETF
SRLN
|
+$3.45M |
| 4 |
Global X MLP ETF
MLPA
|
+$3.31M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$3.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 62.26% |
| 2 | Technology | 7.9% |
| 3 | Financials | 7.39% |
| 4 | Consumer Staples | 7.01% |
| 5 | Healthcare | 5.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Thermo Fisher Scientific
TMO
$258B
| $1.58M | 0.19% |
8,379
-3,101
| -27% | -$562K |
2015 Q3
8 quarters
|
|
|
WBB
102
DELISTED
Westbury Bancorp, Inc.
WBB
| $1.57M | 0.19% |
+78,661
| New | +$1.58M |
2017 Q3
0 quarters
|
|
103
Visa
V
$756B
| $1.55M | 0.19% |
14,705
-3,100
| -17% | -$314K |
2014 Q1
14 quarters
|
|
104
Walt Disney
DIS
$192B
| $1.54M | 0.19% |
15,604
-540
| -3% | -$55.5K |
2013 Q2
17 quarters
|
|
105
Everest Group
EG
$14.6B
| $1.54M | 0.19% |
6,725
-340
| -5% | -$85.7K |
2014 Q2
13 quarters
|
|
106
iShares National Muni Bond ETF
MUB
$49.2B
| $1.53M | 0.19% |
13,815
+4,196
| +44% | +$466K |
2013 Q4
15 quarters
|
|
107
Vanguard Morningstar Small-Cap ETF
VB
$77.8B
| $1.46M | 0.18% |
10,335
-3,415
| -25% | -$465K |
2016 Q3
4 quarters
|
|
108
iShares Select Dividend ETF
DVY
$23B
| $1.46M | 0.18% |
15,534
+1,900
| +14% | +$176K |
2014 Q2
13 quarters
|
|
109
Nasdaq
NDAQ
$52.2B
| $1.44M | 0.18% |
55,830
-31,080
| -36% | -$772K |
2015 Q4
7 quarters
|
|
110
Amgen
AMGN
$237B
| $1.43M | 0.17% |
7,682
-1,825
| -19% | -$323K |
2016 Q3
4 quarters
|
|
111
Vanguard High Dividend Yield ETF
VYM
$81.4B
| $1.43M | 0.17% |
17,594
+5,267
| +43% | +$418K |
2016 Q4
3 quarters
|
|
112
Corning
GLW
$118B
| $1.36M | 0.17% |
45,350
-6,090
| -12% | -$180K |
2014 Q2
13 quarters
|
|
113
DELISTED
Invesco BulletShares 2020 Corporate Bond ETF
BSCK
| $1.34M | 0.16% |
62,481
| – | – |
2015 Q1
10 quarters
|
|
114
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.2B
| $1.31M | 0.16% |
14,881
+3,434
| +30% | +$302K |
2013 Q4
15 quarters
|
|
115
DELISTED
Avanos Medical
AVNS
| $1.28M | 0.16% |
28,480
| – | – |
2014 Q4
11 quarters
|
|
116
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.6B
| $1.26M | 0.15% |
3,854
+251
| +7% | +$79.8K |
2013 Q2
17 quarters
|
|
117
Bristol-Myers Squibb
BMY
$124B
| $1.25M | 0.15% |
19,688
+1,810
| +10% | +$106K |
2013 Q2
17 quarters
|
|
118
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.34B
| $1.23M | 0.15% |
23,033
+411
| +2% | +$21.6K |
2016 Q2
5 quarters
|
|
119
Moody's
MCO
$83.8B
| $1.22M | 0.15% |
8,762
-3,027
| -26% | -$398K |
2015 Q3
8 quarters
|
|
120
Baxter International
BAX
$13.4B
| $1.14M | 0.14% |
18,103
-1,216
| -6% | -$75.1K |
2016 Q4
3 quarters
|
|
121
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
| $1.07M | 0.13% |
12,447
-670
| -5% | -$56.7K |
2015 Q4
7 quarters
|
|
122
Invesco Global Listed Private Equity ETF
PSP
$213M
| $1.07M | 0.13% |
+16,919
| New | +$1.07M |
2017 Q3
0 quarters
|
|
123
DELISTED
Paramount Global Class B
PARA
| $1.05M | 0.13% |
18,084
-4,520
| -20% | -$286K |
2016 Q4
3 quarters
|
|
124
Procter & Gamble
PG
$365B
| $1.01M | 0.12% |
11,060
-200
| -2% | -$18.2K |
2013 Q2
17 quarters
|
|
125
Berkshire Hathaway Class B
BRK.B
$1.13T
| $990K | 0.12% |
5,400
+900
| +20% | +$159K |
2014 Q2
13 quarters
|
|
Similar funds
RC
SRIM
SGI
HHAM
TCC
NNPTE
WIC
KAM
Legacy Private Trust's Q3 2017 Portfolio in Review
As of Q3 2017, Legacy Private Trust held 253 positions worth $822M, up 3.9% from $790M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Legacy Private Trust's Q3 2017 filing shows 23 new, 60 increased, 119 reduced and 20 closed positions. Its largest new stake was Invesco S&P 500 Pure Growth ETF: 368,575 shares worth $7.37M. The largest sale was Invesco FTSE RAFI Emerging Markets ETF, an estimated $5.29M.
By sector, the portfolio is most concentrated in Miscellaneous at 62% of assets, up from 59% a quarter earlier, followed by Technology and Financials.
- Legacy Private Trust's largest Q3 2017 buy was Invesco S&P 500 Pure Growth ETF: 368,575 shares worth $7.37M.
- Legacy Private Trust added most to Vanguard FTSE Developed Markets ETF in Q3 2017, an estimated $13.2M increase.
- Legacy Private Trust's biggest Q3 2017 reduction was Invesco FTSE RAFI Emerging Markets ETF, cutting an estimated $5.29M.
- Legacy Private Trust fully exited iShares iBonds Sep 2018 Term Muni Bond ETF in Q3 2017, selling an estimated $1.88M.
- Legacy Private Trust's ten largest holdings make up 35% of its $822M portfolio in Q3 2017.
- Legacy Private Trust opened 23 new positions and closed 20 in Q3 2017.
- Legacy Private Trust's portfolio value rose 3.9% quarter-over-quarter to $822M.
Based on Legacy Private Trust's 13F filing for Q3 2017, filed 13 Oct 2017.